Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review

Public Health

Volumn 121, Issue 10, 2007, Pages 742-751

  Kohlhammer, Y ^a   Schnoor, M ^a   Schwartz, M ^a   Raspe, H ^a   Schafer T ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Influenza vaccination; Pneumococcal vaccination; Prevention; Review

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

DISEASE CONTROL; DISEASE INCIDENCE; ELDERLY POPULATION; HEALTH SERVICES; HEALTH SURVEY; IMMUNIZATION; INFLUENZA; VACCINATION;

AGED; ARTICLE; DATA ANALYSIS; GERMANY; HEALTH PROMOTION; HUMAN; IMMUNIZATION; INCIDENCE; INFLUENZA VACCINATION; ISRAEL; LUNG DISEASE; MEDLINE; UNITED STATES;

AGED; GERMANY; HUMANS; INFLUENZA, HUMAN; PNEUMOCOCCAL INFECTIONS; VACCINATION;

ASIA; CENTRAL EUROPE; EURASIA; EUROPE; GERMANY; ISRAEL; MIDDLE EAST; NORTH AMERICA; UNITED STATES;

EID: 34548010517     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2007.02.011     Document Type: Article

References (46)

1. Fedson D.S. Adult immunization. Summary of the National Vaccine Advisory Committee Report. JAMA 272 (1994) 1133-1137
2. Gardner P., and Schaffner W. Immunization of adults. N Engl J Med 328 (1993) 1252-1258
3. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46 (1997) 1-24
4. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 (2003) 1780-1785
5. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) 1599. MMWR Recomm Rep 49 (2000) 1-38
6. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
7. Loney P.L., Chambers L.W., Bennett K.J., Roberts J.G., and Stratford P.W. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 19 (1998) 170-176
8. Christenson B., and Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 129 (2002) 515-524
9. D'Argenio P., Adamo B., Coluccio R., D'Apice A., Ferrara M.A., Giugliano F., et al. Influenza vaccination coverage in elderly people, Campania (Italy), 1999. Euro Surveill 6 (2001) 26-30
10. Ehresmann K.R., Ramesh A., Como-Sabetti K., Peterson D.C., Whitney C.G., and Moore K.A. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Prev Med 32 (2001) 409-415
11. Evans M.R., and Watson P.A. Why do older people not get immunised against influenza? A community survey. Vaccine 21 (2003) 2421-2427
12. Figaro M.K., and Belue R. Prevalence of influenza vaccination in a high-risk population. J Ambul Care Manage 28 1 (2005) 24-29
13. Horby P.W., Williams A., Burgess M.A., and Wang H. Prevalence and determinants of influenza vaccination in Australians aged 40 years and over-a national survey. Aust N Z J Public Health 29 1 (2005) 35-37
14. Kaufman Z., and Green M.S. Compliance with influenza and pneumococcal vaccinations in Israel, 1999-2002. Public Health Rev 31 (2003) 71-79
15. Kroneman M.W., van Essen G.A., Tacken M.A., Paget W.J., and Verheij R. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 22 (2004) 2163-2170
16. Luthi J.C., Mean F., Ammon C., and Burnand B. Evaluation of a population-based prevention program against influenza among Swiss elderly people. Swiss Med Wkly 132 (2002) 592-597
17. Mueller D., Wutzler P., and Szues T.D. Influenza vaccination coverage rates in Germany. A population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004. Med Klin (Munich) 100 1 (2005) 6-13
18. Nowalk M.P., Zimmerman R.K., Shen S., Jewell I.K., and Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). J Am Geriatr Soc 52 (2004) 25-30
19. Rehmet S., Ammon A., Pfaff G., Bocter N., and Petersen L.R. Cross-sectional study on influenza vaccination, Germany, 1999-2000. Emerg Infect Dis 8 (2002) 1442-1447
20. Santibanez T.A., Nowalk M.P., Zimmerman R.K., Jewell I.K., Bardella I.J., Wilson S.A., et al. Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc 50 (2002) 1711-1716
21. Wilson D., Lester R., Taylor A., Gill T., Dal Grande E., Litt J., et al. Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaigns. Soz Praventivmed 47 (2002) 91-99
22. Hutchison B.G. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can J Public Health 80 (1989) 271-275
23. MacDonald R., Baken L., Nelson A., and Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 16 (1999) 173-177
24. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., and Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 21 (2003) 1486-1491
25. Marcus A.C., and Crane L.A. Telephone surveys in public health research. Med Care 24 (1986) 97-112
26. Ford E.S. Characteristics of survey participants with and without a telephone: findings from the third National and Nutrition Examination Survey. J Clin Epidemiol 51 (1998) 55-60
27. Kyaw M.H., Wayne B., Holmes E.M., Jones I.G., and Campbell H. Influenza and pneumococcal vaccination in Scottish nursing homes: coverage, policies and reasons for receipt and non-receipt of vaccine. Vaccine 20 (2002) 2516-2522
28. Chi R.C., and Neuzil K.M. The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons. Am J Med Sci 327 (2004) 113-117
29. Nguyen-Van-Tam J.S., and Neal K.R. Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines. Semin Respir Infect 14 (1999) 184-195
30. Ambrosch F., and Fedson D.S. Influenza vaccination in 29 countries: An update to 1997. Pharmacoeconomics 16 Suppl. 1 (1999) 47-54
31. Fedson D.S., Hannoun C., Leese J., Sprenger M.J., Hampson A.W., Bro-Jorgensen K., et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 13 (1995) 623-627
32. Zimmerman R.K. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. American Academy of Family Physicians. Am Fam Physician 60 (1999) 2061-2070
33. Robert-Koch-Institute: Teilnahme an Influenza- und Pneumokokken-Schutzimpfung. Epid Bull 16 (2002) 127-131
34. Nichol K.L., and Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch Intern Med 161 (2001) 2702-2708
35. Sarria-Santamera A., and Timoner J. Influenza vaccination in old adults in Spain. Eur J Public Health 13 (2003) 133-137
36. Fine M.J., Smith M.A., Carson C.A., Meffe F., Sankey S.S., Weissfeld L.A., et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 154 (1994) 2666-2677
37. Jackson L.A., Neuzil K.M., Yu O., Benson P., Barlow W.E., Adams A.L., et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348 (2003) 1747-1755
38. Koivula I., Sten M., Leinonen M., and Makela P.H. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 103 (1997) 281-290
39. Watson L., Wilson B.J., and Waugh N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 20 (2002) 2166-2173
40. Moore R.A., Wiffen P.J., and Lipsky B.A. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract 1 (2000) 1
41. Davis M.M., McMahon S.R., Santoli J.M., Schwartz B., and Clark S.J. A national survey of physician practices regarding influenza vaccine. J Gen Intern Med 17 (2002) 670-676
42. Kroneman M., Paget W.J., and van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill 8 (2003) 130-138
43. Ompad D.C., Galea S., and Vlahov D. Distribution of influenza vaccine to high-risk groups. Epidemiol Rev 28 (2006) 54-70
44. Sisk J.E., Moskowitz A.J., Whang W., Lin J.D., Fedson D.S., McBean A.M., et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 278 (1997) 1333-1339
45. Drinkovic D., Wong C.G., Taylor S.L., Roberts S.A., and Morris A.J. Pneumococcal bacteraemia and opportunities for prevention. N Z Med J 114 (2001) 326-328
46. Butler J.C., and Cetron M.S. Pneumococcal drug resistance: the new "special enemy of old age". Clin Infect Dis 28 (1999) 730-735